No DLTs so far and let’s hope that continues. The images shared clearly demonstrate efficacy. Could we stand a chance for accelerated approval?
I think what is special is also the Cu64-Cu67 pair for diagnostic and treatment. And of course while not an outcome of the trials, FDA and other BP may prefer our pair given the easy of developing them over other imaging and treatment regimes.
- Forums
- ASX - By Stock
- CU6
- Upcoming results
Upcoming results, page-8
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$8.69 |
Change
0.060(0.70%) |
Mkt cap ! $2.746B |
Open | High | Low | Value | Volume |
$8.60 | $8.69 | $8.26 | $10.22M | 1.204M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 795 | $8.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.69 | 10636 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 138 | 9.240 |
2 | 10007 | 9.000 |
1 | 380 | 8.990 |
1 | 500 | 8.960 |
3 | 64 | 8.750 |
Price($) | Vol. | No. |
---|---|---|
8.260 | 2241 | 1 |
8.530 | 213 | 1 |
8.540 | 12 | 1 |
8.700 | 5050 | 2 |
8.750 | 2406 | 1 |
Last trade - 16.10pm 25/09/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, Managing Director and Executive Chairman
David Breeze
Managing Director and Executive Chairman
SPONSORED BY The Market Online